We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Biopharmaceutical firm Dynavax Technologies has partnered with the University of Queensland (UQ) and Coalition for Epidemic Preparedness (CEPI) for the development of a Covid-19 vaccine.